搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Synechococcus sp. Transcriptional repressor NrdR (nrdR) CSB-YP642394SSG
CSB-EP642394SSG
CSB-BP642394SSG
CSB-MP642394SSG
CSB-EP642394SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (metE), partial CSB-YP642395SSG
CSB-EP642395SSG
CSB-BP642395SSG
CSB-MP642395SSG
CSB-EP642395SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 4-hydroxythreonine-4-phosphate dehydrogenase (pdxA) CSB-YP642396SSG
CSB-EP642396SSG
CSB-BP642396SSG
CSB-MP642396SSG
CSB-EP642396SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II D2 protein (psbD1), partial CSB-YP642397SSG1
CSB-EP642397SSG1
CSB-BP642397SSG1
CSB-MP642397SSG1
CSB-EP642397SSG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 30S ribosomal protein S18 (rpsR) CSB-YP642398SSG
CSB-EP642398SSG
CSB-BP642398SSG
CSB-MP642398SSG
CSB-EP642398SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Glutamyl-tRNA (Gln) amidotransferase subunit A (gatA), partial CSB-YP642399SSG
CSB-EP642399SSG
CSB-BP642399SSG
CSB-MP642399SSG
CSB-EP642399SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 30S ribosomal protein S13 (rpsM) CSB-YP642400SSG
CSB-EP642400SSG
CSB-BP642400SSG
CSB-MP642400SSG
CSB-EP642400SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II reaction center protein J (psbJ), partial CSB-YP642401SSG
CSB-EP642401SSG
CSB-BP642401SSG
CSB-MP642401SSG
CSB-EP642401SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP642402SSG
CSB-EP642402SSG
CSB-BP642402SSG
CSB-MP642402SSG
CSB-EP642402SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable transcriptional regulatory protein CYB_1350 (CYB_1350) CSB-YP642403SSG
CSB-EP642403SSG
CSB-BP642403SSG
CSB-MP642403SSG
CSB-EP642403SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. SsrA-binding protein (smpB) CSB-YP642404SSG
CSB-EP642404SSG
CSB-BP642404SSG
CSB-MP642404SSG
CSB-EP642404SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L10 (rplJ) CSB-YP642405SSG
CSB-EP642405SSG
CSB-BP642405SSG
CSB-MP642405SSG
CSB-EP642405SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Translation initiation factor IF-2 (infB), partial CSB-YP642406SSG
CSB-EP642406SSG
CSB-BP642406SSG
CSB-MP642406SSG
CSB-EP642406SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. N-acetylmuramic acid 6-phosphate etherase (murQ) CSB-YP642407SSG
CSB-EP642407SSG
CSB-BP642407SSG
CSB-MP642407SSG
CSB-EP642407SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Elongation factor Tu (tuf) CSB-YP642408SSG
CSB-EP642408SSG
CSB-BP642408SSG
CSB-MP642408SSG
CSB-EP642408SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. NAD (P)H-quinone oxidoreductase subunit H (ndhH) CSB-YP642409SSG
CSB-EP642409SSG
CSB-BP642409SSG
CSB-MP642409SSG
CSB-EP642409SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L27 (rpmA) CSB-YP642410SSG
CSB-EP642410SSG
CSB-BP642410SSG
CSB-MP642410SSG
CSB-EP642410SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. ATP-dependent zinc metalloprotease FtsH (ftsH), partial CSB-YP642411SSG1
CSB-EP642411SSG1
CSB-BP642411SSG1
CSB-MP642411SSG1
CSB-EP642411SSG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP642412SSG
CSB-EP642412SSG
CSB-BP642412SSG
CSB-MP642412SSG
CSB-EP642412SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP642413SSG
CSB-EP642413SSG
CSB-BP642413SSG
CSB-MP642413SSG
CSB-EP642413SSG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>